The prognostic role of matrix metalloproteinase 2 in gastric cancer: A systematic review with meta-analysis

Journal of Cancer Research and Clinical Oncology

Volumn 140, Issue 6, 2014, Pages 1003-1009

  Shen, Weisong ^a   Xi, Hongqing ^a   Wei, Bo ^a   Chen, Lin ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Gastric cancer; Matrix metalloproteinase 2; Meta analysis; Prognosis

Indexed keywords

GELATINASE A;

ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; DISTANT METASTASIS; EMBASE; HUMAN; LYMPH NODE METASTASIS; MEDLINE; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; SYSTEMATIC REVIEW; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR VOLUME;

CASE-CONTROL STUDIES; HUMANS; MATRIX METALLOPROTEINASE 2; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84901333520     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1630-6     Document Type: Article

References (33)

1. Alakus H, Grass G, Hennecken JK, Bollschweiler E, Schulte C, Drebber U, Baldus SE, Metzger R, Holscher AH, Monig SP (2008) Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer. Histol Histopathol 23(8):917-923
2. Allgayer H, Babic R, Beyer BC, Grutzner KU, Tarabichi A, Schildberg FW, Heiss MM (1998) Prognostic relevance of MMP-2 (72-kD collagenase IV) in gastric cancer. Oncology 55(2):152-160 (Pubitemid 28052260)
3. Chen Y, Huang Y, Huang Y, Xia X, Zhang J, Zhou Y, Tan Y, He S, Qiang F, Li A, Re OD, Li G, Zhou J (2013) JWA suppresses tumor angiogenesis via Sp1-activated matrix metalloproteinase-2 and its prognostic significance in human gastric cancer. Carcinogenesis. doi:10.1093/carcin/bgt311
4. Dalberg K, Eriksson E, Enberg U, Kjellman M, Backdahl M (2000) Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer. World J Surg 24(3):334-340 (Pubitemid 30117763)
5. Deveci MS, Deveci G (2007) Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma. Gastric Cancer 10(2):112-116. doi:10.1007/s10120-007-0418-7 (Pubitemid 46955939)
6. Dicken BJ, Graham K, Hamilton SM, Andrews S, Lai R, Listgarten J, Jhangri GS, Saunders LD, Damaraju S, Cass C (2006) Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques. Ann Surg 243(1):64-73 (Pubitemid 43054056)
7. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed) 315(7109):629-634 (Pubitemid 27387172)
8. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer J Int Du Cancer 127(12):2893-2917. doi:10.1002/ijc.25516
9. Fondevila C, Metges JP, Fuster J, Grau JJ, Palacin A, Castells A, Volant A, Pera M (2004) p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer 90(1):206-215. doi:10.1038/sj.bjc.6601455 (Pubitemid 38174963)
10. Hwang TL, Lee LY, Wang CC, Liang Y, Huang SF, Wu CM (2010) Claudin-4 expression is associated with tumor invasion, MMP-2 and MMP-9 expression in gastric cancer. Exp Ther Med 1(5):789-797. doi:10.3892/etm.2010.116
11. Kim BS, Cho SW, Min SK, Lee BH (2011) Differences in prognostic factors between early and advanced gastric cancer. Hepatogastroenterology 58(107-108):1032-1040
12. Kjellman M, Enberg U, Hoog A, Larsson C, Holst M, Farnebo LO, Sato H, Backdahl M (1999) Gelatinase A and membrane-type 1 matrix metalloproteinase mRNA : expressed in adrenocortical cancers but not in adenomas. World J Surg 23(3):237-242 (Pubitemid 29091690)
13. Kubben FJ, Sier CF, van Duijn W, Griffioen G, Hanemaaijer R, van de Velde CJ, van Krieken JH, Lamers CB, Verspaget HW (2006) Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer. Br J Cancer 94(7):1035-1040. doi:10.1038/sj.bjc.6603041
14. McCawley LJ, Matrisian LM (2000) Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 6(4):149-156 (Pubitemid 30171365)
15. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. doi:10.1371/journal.pmed.1000097
16. Monig SP, Baldus SE, Hennecken JK, Spiecker DB, Grass G, Schneider PM, Thiele J, Dienes HP, Holscher AH (2001) Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma. Histopathology 39(6):597-602 (Pubitemid 34017133)
17. Mrena J, Wiksten JP, Nordling S, Kokkola A, Ristimaki A, Haglund C (2006) MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer. J Clin Pathol 59(6):618-623. doi:10.1136/jcp.2005.033761 (Pubitemid 43886046)
18. Nomura H, Fujimoto N, Seiki M, Mai M, Okada Y (1996) Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int J Cancer 69(1):9-16. doi:10.1002/(sici)1097-0215(19960220)69:1〈9:aid-ijc3〉3.0.co;2-8 (Pubitemid 26083264)
19. Nordmann AJ, Kasenda B, Briel M (2012) Meta-analyses: what they can and cannot do. Swiss Med Wkly 142:w13518. doi:10.4414/smw.2012.13518
20. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17(24):2815-2834 (Pubitemid 28562978)
21. Peng CW, Liu XL, Liu X, Li Y (2010) Co-evolution of cancer microenvironment reveals distinctive patterns of gastric cancer invasion: laboratory evidence and clinical significance. J Transl Med 8:101. doi:10.1186/1479-5876-8-101
22. Rundhaug JE (2005) Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9(2):267-285
23. Seshadri RA, Jayanand SB, Ranganathan R (2011) Prognostic factors in patients with node-negative gastric cancer: an Indian experience. World J Surg Oncol 9:48. doi:10.1186/1477-7819-9-48
24. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603-605. doi:10.1007/s10654-010-9491-z
25. Steels E, Paesmans M, Berghmans T, Branle F, Lemaitre F, Mascaux C, Meert AP, Vallot F, Lafitte JJ, Sculier JP (2001) Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J 18(4):705-719 (Pubitemid 33040631)
26. Stetler-Stevenson WG (2001) The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg Oncol Clin N Am 10 (2):383-392
27. Sundblad A, Ricci L (1998) MMP-2 expression (type IV collagenase) in gastric cancer. Acta Gastroenterol Latinoam 28(4):287-290
28. Takahashi Y, Kitadai Y, Ellis LM, Bucana CD, Fidler IJ, Mai M (2002) Multiparametric in situ mRNA hybridization analysis of gastric biopsies predicts lymph node metastasis in patients with gastric carcinoma. Jpn J Cancer Res 93(11):1258-1265 (Pubitemid 36032990)
29. Wang G, Wang W, Zhou J, Yang X (2013) Correlation between telomerase activity and matrix metalloproteinases 2 expression in gastric cancer. Cancer Biomark 13(1):21-28. doi:10.3233/cbm-130332
30. Xing X, Tang YB, Yuan G, Wang Y, Wang J, Yang Y, Chen M (2013) The prognostic value of E-cadherin in gastric cancer: a meta-analysis. Int J Cancer 132(11):2589-2596. doi:10.1002/ijc.27947
31. Yasui W, Hata J, Yokozaki H, Nakatani H, Ochiai A, Ito H, Tahara E (1988) Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma. Int J Cancer 41(2):211-217 (Pubitemid 18061145)
32. Zhao D, Xu H, Li K, Sun Z (2010) Prognostic factors for patients after curative resection for proximal gastric cancer. J Huazhong Univ Sci Technol Med Sci (4):530-535. doi:10.1007/s11596-010-0463-z
33. Zhou Y, Li G, Wu J, Zhang Z, Wu Z, Fan P, Hao T, Zhang X, Li M, Zhang F, Li Q, Lu B, Qiao L (2010) Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer. Tumour Biol 31(6):549-558. doi:10.1007/s13277-010- 0068-y